Expansion opportunities Gedeon Richter is investing to triple production capacity, expand warehouse and laboratories, and push into biosimilars through a dedicated Biotech unit. This growth trajectory suggests increased demand for contract manufacturing, logistics, and regulatory support services to scale supply for global markets.

Gyn health leadership Since 2011, the company has established a strong foothold in vaginal health in Germany, positioning it as a leading partner for women’s health therapies. There is potential to cross-sell partnerships for gynecological generics, biosimilars, and licensed products to expand portfolio access in EU markets.

R&D driven With a focus on sustainable growth, heavy investment in R&D and the world’s largest R&D center in Hungary, there are opportunities to collaborate on early-stage development, clinical trial partnerships, and technology licensing to accelerate innovative therapies.

Global access The company aims to improve worldwide access to affordable medicines, which aligns with partnerships for distribution, pricing negotiations, and market-entry support in emerging and frontier markets seeking affordable biologics and generics.

Technology stack fit The tech landscape includes SAP, production planning, analytics tools, and digital marketing tags. This suggests potential for selling enterprise services such as advanced supply chain optimization, data analytics, ERP integration, and digital adoption consulting to streamline operations.